Treatment for Persistent Bartonella Infection

First-Line Combination Therapy Options

The Centers for Disease Control and Prevention recommends doxycycline (100 mg twice daily) plus rifampin (300-600 mg daily) for at least 3 months as the first-line treatment for persistent Bartonella infection, especially for cases involving the central nervous system or other severe manifestations 1, 2

For patients with severe disease or evidence of bacteremia, the Centers for Disease Control and Prevention suggests doxycycline (100 mg twice daily) plus gentamicin (3 mg/kg/day IV or IM in 1 dose for 2 weeks) 1, 3
Azithromycin (500 mg daily) plus rifampin (300-600 mg daily) can be used for patients who cannot tolerate doxycycline, as recommended by the Centers for Disease Control and Prevention 1

The Centers for Disease Control and Prevention recommends a minimum treatment duration of 3 months for persistent infection 1, 3
Longer treatment courses (4-6 months) may be necessary for patients with severe or complicated disease, according to the Centers for Disease Control and Prevention 3, 4

Regular clinical assessment for symptom improvement should be performed every 2-4 weeks, as advised by the Centers for Disease Control and Prevention 3
Patients taking doxycycline should be cautioned about pill-associated ulcerative esophagitis and advised to take medication with adequate fluid and not immediately before bedtime, according to the Centers for Disease Control and Prevention 3

Quinolones and trimethoprim-sulfamethoxazole are not recommended due to variable in vitro activity and inconsistent clinical response, as stated by the Centers for Disease Control and Prevention 1, 3
Penicillins and first-generation cephalosporins have no in vivo activity against Bartonella and should be avoided, according to the Centers for Disease Control and Prevention 1, 4

After successful treatment, consider long-term suppressive therapy with doxycycline or a macrolide if the patient is immunocompromised, as recommended by the Centers for Disease Control and Prevention 3
Address potential sources of reinfection, such as flea-infested cats or exposure to body lice, and implement comprehensive flea control for household pets under veterinary supervision, as advised by the Centers for Disease Control and Prevention 3, 4

The American Academy of Family Physicians recommends continuing treatment until the patient demonstrates significant clinical improvement, not just completion of an arbitrary timeframe 5
Relapse or reinfection is common with Bartonella, making long-term suppression particularly important in high-risk patients 5